Abstract
Several epidemiological data suggest the involvement of hepatitis C virus (HCV) in the pathogenesis of some histotypes of B-cell non-Hodgkin's lymphomas, in particular immunocytoma. We report a patient with HCV-associated immunocytoma, first treated with six courses of fludarabine. A partial response was achieved and subsequent therapy with alpha-interferon resulted in the clearance of the virus and a long-lasting complete clinical and histological remission of the lymphoproliferative disease.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Hepatitis C / complications
-
Hepatitis C / drug therapy*
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use*
-
Lymphoma, Non-Hodgkin / drug therapy*
-
Lymphoma, Non-Hodgkin / virology
-
Male
-
Recombinant Proteins
-
Remission Induction
-
Time Factors
-
Vidarabine / analogs & derivatives*
-
Vidarabine / therapeutic use
Substances
-
Immunosuppressive Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Vidarabine
-
fludarabine